Article
Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.
The American journal of case reports - 16 Feb 2022
Salama Hind, Fahed Alzayed Mohammed, Alharbi Khalid Ghazi, Khattak Zohra, Omer Mohamed H, Tahir Leena, ALhejazi Ayman
Abstract excerpt
BACKGROUND Erdheim-Chester disease (ECD) is a clonal disease characterized by histiocytic infiltration of multiple organ systems. As ECD is a rare disorder with variable presentations, its diagnosis and management can present a significant clinical challenge. The diagnosis of ECD requires several clinical, radiological, and histological criteria. Since approximately 75% of ECD patients harbor a mutation in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.